Saffron Walden, United Kingdom

Christopher Matheson

This inventor holds 1 USPTO granted patent. Top assignee: Sitryx Therapeutics Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christopher Matheson. Retrieved from https://idiyas.com/inventor/christopher-matheson-cyy3174o

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christopher Matheson: Innovator in Compound Development

Introduction

Christopher Matheson is a notable inventor based in Saffron Walden, GB. He has made significant contributions to the field of compound development, showcasing his expertise through his innovative work.

Latest Patents

Matheson holds 1 patent related to compounds of formula (I) and its associated aspects. This invention highlights his commitment to advancing scientific knowledge and practical applications in his field.

Career Highlights

Christopher Matheson is currently employed at Sitryx Therapeutics Limited, where he continues to push the boundaries of innovation. His work at this company reflects his dedication to developing new therapeutic solutions.

Collaborations

Matheson collaborates with talented individuals such as Alessandro Mazzacani and Paulette Greenidge. These partnerships enhance the creative process and contribute to the success of their projects.

Conclusion

Christopher Matheson is a distinguished inventor whose work in compound development is paving the way for future innovations. His contributions to Sitryx Therapeutics Limited and collaborations with other professionals underscore his impact in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…